Celldex Therapeutics, Inc. (CLDX)
27.53
-1.40
(-4.84%)
USD |
NASDAQ |
Oct 16, 16:00
27.53
0.00 (0.00%)
After-Hours: 18:24
Celldex Therapeutics Profit Margin (Quarterly) : -334.1K% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -334.1K% |
| March 31, 2026 | -524.6K% |
| December 31, 2025 | -67.20K% |
| September 30, 2025 | |
| June 30, 2025 | -7.75K% |
| March 31, 2025 | -7.74K% |
| December 31, 2024 | -4.01K% |
| September 30, 2024 | -1.32K% |
| June 30, 2024 | -1.43K% |
| March 31, 2024 | -21.03K% |
| December 31, 2023 | -1.05K% |
| September 30, 2023 | -2.52K% |
| June 30, 2023 | -11.38K% |
| March 31, 2023 | -3.04K% |
| December 31, 2022 | -1.64K% |
| September 30, 2022 | -6.58K% |
| June 30, 2022 | -22.09K% |
| March 31, 2022 | -13.25K% |
| December 31, 2021 | -6.03K% |
| September 30, 2021 | -13.37K% |
| June 30, 2021 | -384.3% |
| March 31, 2021 | -2.41K% |
| December 31, 2020 | -578.6% |
| September 30, 2020 | -2.13K% |
| June 30, 2020 | -4.67K% |
| Date | Value |
|---|---|
| March 31, 2020 | -462.8% |
| December 31, 2019 | -1.18K% |
| September 30, 2019 | -2.09K% |
| June 30, 2019 | -1.65K% |
| March 31, 2019 | -1.21K% |
| December 31, 2018 | -533.0% |
| September 30, 2018 | -769.7% |
| June 30, 2018 | -593.8% |
| March 31, 2018 | -2.90K% |
| December 31, 2017 | -111.1% |
| September 30, 2017 | -671.8% |
| June 30, 2017 | -746.0% |
| March 31, 2017 | -2.23K% |
| December 31, 2016 | -1.72K% |
| September 30, 2016 | -1.33K% |
| June 30, 2016 | -2.30K% |
| March 31, 2016 | -2.66K% |
| December 31, 2015 | -1.82K% |
| September 30, 2015 | -3.12K% |
| June 30, 2015 | -1.49K% |
| March 31, 2015 | -6.21K% |
| December 31, 2014 | -2.15K% |
| September 30, 2014 | -2.55K% |
| June 30, 2014 | -4.78K% |
| March 31, 2014 | -7.19K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Gilead Sciences, Inc. | -134.2% |
| ACADIA Pharmaceuticals, Inc. | 10.23% |
| Alnylam Pharmaceuticals, Inc. | 12.74% |
| Anika Therapeutics, Inc. | 10.15% |
| Savara, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -50.91% |
| Return on Assets | -46.71% |
| Return on Invested Capital | -50.66% |
| Gross Profit Margin (Quarterly) | -4.00K% |
| Operating Margin (Quarterly) | -366.5K% |
| Return on Net Operating Assets | -809.5% |